Quipt Home Medical Corp Revenue per Employee (QIPT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Quipt Home Medical Corp   (NASDAQ: QIPT)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Quipt Home Medical 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 31.96% in the first quarter 2026, year on year to cumulative value of $265 million, Quipt Home Medical 's revenue per employee grew on a trailing twelve months basis to $ 165,609, this is below the company average.
Within the Healthcare sector Employees of 43 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 507, from total ranking in previous quarter at 2704. Quipt Home Medical has 1,600 employees.


What is Sales per Employee Ratio?







QIPT Revenue per Employee (Dec 31 2025)
I. Quarter
(Sep 30 2025)
IV. Quarter
(Jun 30 2025)
III. Quarter
(Mar 31 2025)
II. Quarter
(Dec 31 2024)
I. Quarter
Y / Y Revenue Change 31.96 % -72.22 % -4.07 % -6.33 % -1.9 %
Sales per Employee (TTM) $ 165,609 153,349 264,351 265,894 268,316
QIPT's Total Ranking # 507 # 2704 # 1642 # 1395 # 0
Seq. Revenue Change 18.57 % 17.2 % 1.59 % -6.52 % -75.04 %


Revenue per Employee Company Ranking
Within: No.
Healthcare Facilities Industry # 4
Healthcare Sector # 44
Overall Market # 507

Revenue per Employee Statistics
High Average Low
$ 366,509 $ 217,681 $ 138,589
(Mar 31 2025)   (Sep 30 2023)



Financial Statements
Quipt Home Medical 's Revenue MRQ $ 81 Millions Visit QIPT's Income Statement
Quipt Home Medical 's Revenues TTM $ 265 Millions Visit QIPT's aggregate revenue growth
What are QIPT's Sales? Visit QIPT's Sales by Segment


  News about Quipt Home Medical Corp Revenue per employee

Quipt Home Medical: A Strategic Growth Path and Strengthened Shareholder Commitments

In a rapidly evolving healthcare landscape, Quipt Home Medical Corp. a leader in home medical equipment focusing on end-to-end respiratory care, is making significant strides to bolster shareholder value and corporate governance. The recent release announces a series of strategic initiatives that not only reinforce the company’s growth narrative but also highlight its dedication to responsible management in the face of increasing scrutiny from shareholders. Key Developments for Quipt Home Medical1. Commitment to Shareholder Value: Quipt reaffirmed its dedication to enhancing shareholder value in its latest communications, particularly in response to feedback from Kanen Wealth Management. This commitment reflects a broader trend among public companies to prioritize shareholder interests, especially amidst pressures for better governance and transparency.




Other Ratios
Quipt Home Medical 's Income per Employee
Employees in Healthcare Facilities
Healthcare Facilities Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
QIPT's Revenue per Employee versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for QIPT's Competitors
Revenue per Employee for QIPT's Suppliers
Revenue per Employee for QIPT's Customers

You may also want to know
QIPT's Sales Growth Rates QIPT's Pe Price to earnings ratio QIPT's Receivables Turnover Ratio QIPT's Stock Quote
QIPT's Net Income Growth Rates QIPT's Ps Price to Sales ratio QIPT's Sales per Employee QIPT's Asset Turnover Ratio
QIPT's Net Margin QIPT's Pb Price to Book ratio QIPT's Financial Strength Ratios QIPT's Dividend Payout Ratio
Date modified: 2026-07-07T13:06:03+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Enovis Corp  287,823.25 $ 2,245.597  Million 7,802 
Coherus Oncology inc   286,884.35 $ 42.172  Million 147 
Solana Company  286,523.81 $ 6.017  Million 21 
Voyager Therapeutics Inc   286,340.43 $ 40.374  Million 141 
Cytek Biosciences Inc   285,542.74 $ 200.451  Million 702 
West Pharmaceutical Services Inc   284,629.63 $ 3,074.000  Million 10,800 
Omada Health Inc   282,954.15 $ 259.186  Million 916 
Becton Dickinson And Company  282,625.00 $ 20,349.000  Million 72,000 
Viridian Therapeutics Inc   281,091.27 $ 70.835  Million 252 
Sangamo Therapeutics Inc   278,535.21 $ 39.552  Million 142 
Zeo Scientifix Inc   277,750.00 $ 5.555  Million 20 
The Cooper Companies Inc   276,740.00 $ 4,151.100  Million 15,000 
International Stem Cell Corporation  275,757.58 $ 9.100  Million 33 
Ispecimen inc   275,571.14 $ 1.929  Million 7 
Intelligent Bio Solutions Inc   275,486.31 $ 3.581  Million 13 
Beam Therapeutics Inc   273,469.67 $ 139.743  Million 511 
Lifeward ltd   272,024.69 $ 22.034  Million 81 
Standard Biotools Inc   271,588.69 $ 105.648  Million 389 
Champions Oncology Inc   270,766.36 $ 57.944  Million 214 
Cytosorbents Corporation  270,708.21 $ 34.921  Million 129 
Iovance Biotherapeutics inc   270,258.46 $ 263.502  Million 975 
Ceribell Inc   269,951.07 $ 88.274  Million 327 
Personalis Inc   267,876.92 $ 69.648  Million 260 
Cervomed Inc   267,100.67 $ 4.007  Million 15 
Opko Health Inc   266,760.00 $ 606.879  Million 2,275 
Vycor Medical Inc   266,200.00 $ 1.863  Million 7 
Biodesix Inc   264,967.07 $ 88.499  Million 334 
Nurix Therapeutics Inc   264,921.14 $ 83.980  Million 317 
Dentsply Sirona Inc   262,857.14 $ 3,680.000  Million 14,000 
Prenetics Global Limited  262,257.14 $ 91.790  Million 350 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.